Planta Med 2009; 75(12): 1279-1285
DOI: 10.1055/s-0029-1185561
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Effects of Estradiol Benzoate, Raloxifen and an Ethanolic Extract of Cimicifuga racemosa in Nonclassical Estrogen Regulated Organs of Ovariectomized Rats

Dana Seidlova-Wuttke1 , Hubertus Jarry1 , Wolfgang Wuttke1
  • 1Department of Endocrinology, Georg-August-University Goettingen, Goettingen, Germany
Further Information

Publication History

received Sept. 30, 2008 revised March 4, 2009

accepted March 12, 2009

Publication Date:
06 April 2009 (online)

Abstract

The special extract of Cimicifuga racemosa (CR) BNO 1055 was shown to have bone protective effects without exerting estrogenic effects in the uterus or mammary gland. Whether the effects of CR BNO 1055 would be exerted in other organs that also express estrogen receptors (ERs) but in which the effects of estrogens and of the selective estrogen receptor modulator raloxifen (Ral) were not thoroughly studied was therefore investigated in the present contribution. Rats were ovariectomized (ovx) and their food immediately substituted with estradiol benzoate (EB), Ral or 2 doses of CR BNO 1055 for 3 months. Expressions of estrogen receptor alpha (ERα), estrogen receptor beta (ERβ) and of insulin-like growth factor-1 (IGF-1) genes were determined in the vagina, liver, thyroid gland, lung, spleen, colon and kidney by means of quantitative RT-PCRs. Body weights in all treatment groups were significantly reduced and uterine weights in the EB treated animals were largely and in the Ral treated animals slightly but significantly increased. CR BNO 1055 was without effects in the uterus. We tested 3 genes: ERα gene expression was significantly reduced in the vagina, liver and kidney and remained unaffected in all other organs with the exception of the thyroid gland where ERα gene expression was stimulated by EB, Ral had – if any – similar effects in these organs. The CR extract BNO 1055 was devoid of any effect on ERα gene expression. ERβ gene expression was suppressed in the vagina and colon by EB and this effect was shared by Ral in the colon. In the thyroid, EB and Ral stimulated ERβ gene expression. Expression of IGF-1 gene was stimulated by EB and CR BNO 1055 in the vagina and kidney and inhibited by EB and Ral in the liver. No effects were observed by CR BNO 1055 in these organs. The effects of Ral, if occurring, were similar to those of EB while CR BNO 1055 was ineffective in all organs but the vagina. In the colon, reduced ERβ gene activity may augment ERα mediated effects. In all other organs the effects of ER await further investigation. The CR BNO 1055 did not show any activity pattern which would be similar to the pattern observed under EB or Ral. Therefore the observed effects of CR BNO 1055 in these organs are most likely not estrogenic in nature.

References

  • 1 Seidlova-Wuttke D, Hesse O, Jarry H, Christoffel V, Spengler B, Becker T, Wuttke W. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta.  Eur J Endocrinol. 2003;  149 351-362
  • 2 Seidlova-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus.  Maturitas. 2003;  44 (Suppl. 1) S39-S50
  • 3 Lindberg M K, Moverare S, Skrtic S, Gao H, Dahlmann-Wright K, Gustafsson J A, Ohlsson C. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice.  Mol Endocrinol. 2003;  17 203-208
  • 4 Herynk M H, Fuqua S A. Estrogen receptor mutations in human disease.  Endocr Rev. 2004;  25 869-898
  • 5 Smith C L, O'Malley B W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators.  Endocr Rev. 2004;  25 45-71
  • 6 Clarke R, Liu M C, Bouker K B, Gu Z, Lee R Y, Zhu Y, Skaar T C, Gomez B, O'Brien K, Wang Y, Hilakivi-Clarke L A. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.  Oncogene. 2003;  22 7316-7339
  • 7 Jetten A M, De Luca L M, Nelson K, Schroeder W, Burlingame S, Fujimoto W. Regulation of cornifin alpha expression in the vaginal and uterine epithelium by estrogen and retinoic acid.  Mol Cell Endocrinol. 1996;  123 7-15
  • 8 Wang H, Eriksson H, Sahlin L. Estrogen receptors alpha and beta in the female reproductive tract of the rat during the estrous cycle.  Biol Reprod. 2000;  63 1331-1340
  • 9 Miyagawa S, Suzuki A, Katsu Y, Kobayash M, Goto M, Handa H, Watanabe H, Iguchi T. Persistent gene expression in mouse vagina exposed neonatally to diethylstilbestrol.  J Mol Endocrinol. 2004;  32 663-677
  • 10 Stavreus-Evers A, Parini P, Freyschuss B, Elger W, Reddersen G, Sahlin L, Eriksson H. Estrogenic influence on the regulation of hepatic estrogen receptor-alpha and serum level of angiotensinogen in female rats.  J Steroid Biochem Mol Biol. 2001;  78 83-88
  • 11 Escalada J, Sanchez-Franco F, Velasco B, Cacicedo L. Regulation of growth hormone (GH) gene expression and secretion during pregnancy and lactation in the rat: role of insulin-like growth factor-I, somatostatin, and GH-releasing hormone.  Endocrinology. 1997;  138 3435-3443
  • 12 Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, Kotchen J M, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.  JAMA. 2002;  288 321-333
  • 13 Wong N A, Malcomson R D, Jodrell D I, Groome N P, Harrison D J, Saunders P T. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates.  J Pathol. 2005;  207 53-60
  • 14 Koehler K F, Helguero L A, Haldosen L A, Warner M, Gustafsson J A. Reflections on the discovery and significance of estrogen receptor beta.  Endocr Rev. 2005;  26 465-478
  • 15 Ibrahim Y H, Yee D. Insulin-like growth factor-I and cancer risk.  Growth Horm IGF Res. 2004;  14 261-269
  • 16 Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055.  Maturitas. 2003;  44 (Suppl. 1) S31-S38
  • 17 Wober J, Weisswange I, Vollmer G. Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens.  J Steroid Biochem Mol Biol. 2002;  83 227-233
  • 18 Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G. Antiestrogenic activities of Cimicifuga racemosa extracts.  J Steroid Biochem Mol Biol. 2002;  80 125-130
  • 19 Mahmood I. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions.  J Pharm Pharmacol. 1998;  50 493-499
  • 20 Schneider K, Oltmanns J, Hassauer M. Allometric principles for interspecies extrapolation in toxicological risk assessment – empirical investigations.  Regul Toxicol Pharmacol. 2004;  39 334-347
  • 21 Seidlova-Wuttke D, Thelen P, Wuttke W. Inhibitory effects of a black cohosh (Cimicifuga racemosa) extract on prostate cancer.  Planta Med. 2006;  72 521-526
  • 22 Schlecht C, Klammer H, Jarry H, Wuttke W. Effects of estradiol, benzophenone-2 and benzophenone-3 on the expression pattern of the estrogen receptors (ER) alpha and beta, the estrogen receptor-related receptor 1 (ERR1) and the aryl hydrocarbon receptor (AhR) in adult ovariectomized rats.  Toxicology. 2004;  205 123-130
  • 23 Spreafico E, Bettini E, Pollio G, Maggi A. Nucleotide sequence of estrogen receptor cDNA from Sprague-Dawley rat.  Eur J Pharmacol. 1992;  227 353-356
  • 24 Schoenfeld J R, Vasser M, Jhurani P, Ng P, Hunter J J, Ross Jr J, Chien K R, Lowe D G. Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy.  J Mol Cell Cardiol. 1998;  30 2269-2280
  • 25 Gentry R T, Wade G N. Sex differences in sensitivity of food intake, body weight, and running-wheel activity to ovarian steroids in rats.  J Comp Physiol Psychol. 1976;  90 747-754
  • 26 Ahdieh H B, Wade G N. Effects of hysterectomy on sexual receptivity, food intake, running wheel activity, and hypothalamic estrogen and progestin receptors in rats.  J Comp Physiol Psychol. 1982;  96 886-892
  • 27 Mayes J S, Watson G H. Direct effects of sex steroid hormones on adipose tissues and obesity.  Obes Rev. 2004;  5 197-216
  • 28 Tarnopolsky M A. Sex differences in exercise metabolism and the role of 17-beta estradiol.  Med Sci Sports Exerc. 2008;  40 648-654
  • 29 Kretzschmar G, Nisslein T, Zierau O, Vollmer G. No estrogen-like effects of an isopropanolic extract of Rhizoma Cimicifugae racemosae on uterus and vena cava of rats after 17 day treatment.  J Steroid Biochem Mol Biol. 2005;  97 271-277
  • 30 Kalra M, Mayes J, Assefa S, Kaul A K, Kaul R. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.  World J Gastroenterol. 2008;  14 5945-5961
  • 31 Cosman F, Baz-Hecht M, Cushman M, Vardy M D, Cruz J D, Nieves J W, Zion M, Lindsay R. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized controlled study and review of the literature.  Thromb Res. 2005;  116 1-13
  • 32 Doerge D R, Chang H C. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo.  J Chromatogr B Analyt Technol Biomed Life Sci. 2002;  777 269-279
  • 33 Siracusa M C, Overstreet M G, Housseau F, Scott A L, Klein S L. 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells.  J Immunol. 2008;  180 1423-1431
  • 34 Giroux V, Lemay F, Bernatchez G, Robitaille Y, Carrier J C. Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice.  Int J Cancer. 2008;  123 303-311
  • 35 Mukundan H, Resta T C, Kanagy N L. 17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression.  Am J Physiol Regul Integr Comp Physiol. 2002;  283 R496-R504

Prof. Dr. W. Wuttke

Department of Endocrinology
University Medical Center Göttingen
George-August-University

Robert-Koch-Str. 40

37075 Goettingen

Germany

Phone: + 49 5 51 39 67 14

Fax: + 49 5 51 39 65 18

Email: ufkendo@med.uni-goettingen.de

    >